SLPI regulates the proliferation, migration, and invasion capabilities of HCC cells via apoptosis through the mitogen-activated protein kinase (MAPK) signaling pathway [22], indicating its potential as both a tumor suppressor and a biomarker for HCC prognosis and treatment [21]. Here, WNK2 is linked to hepatocellular carcinoma.